Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary: The Senior Director, CMC Operations, is responsible for leading and coordinating the company’s Chemistry, Manufacturing, and Controls (CMC) operational strategy across development and commercial readiness activities. This role ensures that CMC projects progress efficiently from early development through clinical and regulatory milestones by aligning internal teams, external partners, and technical strategy. Reporting to the Chief Technical Operations & Quality Officer, this role will serve as a central operational leader across Technical Operations, Regulatory, Quality, and Project Management to ensure manufacturing plans, timelines, and deliverables support the company’s broader development goals. This role requires a highly collaborative leader who is comfortable working in a fast-paced biotech environment and balancing strategic planning with hands-on execution.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
101-250 employees